These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35719404)

  • 1. A Novel Defined Hypoxia-Related Gene Signature for Prognostic Prediction of Patients With Ewing Sarcoma.
    Jiang R; Hu J; Zhou H; Wei H; He S; Xiao J
    Front Genet; 2022; 13():908113. PubMed ID: 35719404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel hypoxia-related gene signature for predicting prognoses that correlate with the tumor immune microenvironment in NSCLC.
    Li Z; Cui Y; Zhang S; Xu J; Shao J; Chen H; Chen J; Wang S; Zeng M; Zhang H; Lu S; Qian ZR; Xing G
    Front Genet; 2023; 14():1115308. PubMed ID: 37091782
    [No Abstract]   [Full Text] [Related]  

  • 3. A seven-lncRNA signature for predicting Ewing's sarcoma.
    Chen Z; Wang X; Wang G; Xiao B; Ma Z; Huo H; Li W
    PeerJ; 2021; 9():e11599. PubMed ID: 34178467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
    Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
    Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycolysis-Metabolism-Related Prognostic Signature for Ewing Sarcoma Patients.
    Jia F; Liu L; Weng Q; Zhang H; Zhao X
    Mol Biotechnol; 2023 Sep; ():. PubMed ID: 37775679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of myeloid signature genes for predicting prognosis and immune landscape in Ewing sarcoma.
    Zhang Z; Shi Y; Zhu Z; Fu J; Liu D; Liu X; Dang J; Tao H; Fan H
    Cancer Sci; 2023 Apr; 114(4):1240-1255. PubMed ID: 36478349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of lactate-related signatures correlates with immunosuppressive microenvironment and prognostic prediction in ewing sarcoma.
    Zhang Z; Pan J; Cheng D; Shi Y; Wang L; Mi Z; Fu J; Tao H; Fan H
    Front Genet; 2022; 13():965126. PubMed ID: 36092937
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognosis Implication of a Novel Metabolism-Related Gene Signature in Ewing Sarcoma.
    Chen ZY; Yang H; Bu J; Chen Q; Yang Z; Li H
    J Oncol; 2021; 2021():3578949. PubMed ID: 34925508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
    Wang Y; Song F; Zhang X; Yang C
    Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma.
    Wen K; Yan Y; Shi J; Hu L; Wang W; Liao H; Li H; Zhu Y; Mao K; Xiao Z
    Front Mol Biosci; 2021; 8():809672. PubMed ID: 34977159
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
    Yan Z; He M; He L; Wei L; Zhang Y
    Front Immunol; 2021; 12():723271. PubMed ID: 34925311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma.
    Li Q; Jin L; Jin M
    Front Genet; 2021; 12():613890. PubMed ID: 34194464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Explore the impact of hypoxia-related genes (HRGs) in Cutaneous melanoma.
    Ke G; Cheng N; Sun H; Meng X; Xu L
    BMC Med Genomics; 2023 Jul; 16(1):160. PubMed ID: 37422626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ductal adenocarcinoma.
    Li A; Ye B; Lin F; Wang Y; Miao X; Jiang Y
    Precis Clin Med; 2022 Jun; 5(2):pbac010. PubMed ID: 35694712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma.
    Lin Z; Xu Q; Miao D; Yu F
    Front Oncol; 2021; 11():644416. PubMed ID: 33828988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Hypoxia-Related Signature for Predicting Prognosis, Cellular Processes, Immune Microenvironment and Targeted Compounds in Lung Squamous Cell Carcinoma.
    Wu G; Zhu Z; Yang Z; He M; Ren K; Dong Y; Xue Q
    Int J Gen Med; 2022; 15():3991-4006. PubMed ID: 35437352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bioinformatics analysis and an experimental validation of the hypoxia-related prognostic model.
    Zhou L; Zhang W; Ni H; Liu J; Sun H; Liang Z; Wang R; Xue X; Chen K; Li W
    J Gastrointest Oncol; 2023 Jun; 14(3):1504-1524. PubMed ID: 37435230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.